Altimmune, Inc.

NASDAQ:ALT

Biotechnology

Healthcare
$1.39 +3.09%

+$0.08 today

Market cap
$270.48M
Beta
0.23
P/E (TTM)
-3.7
EPS (TTM)
-$0.73
52W Low $2.56High $7.73

Volume 4.69M

Average 3.81M

Balance Sheet

Inspect the capital base behind the business.

Assets

$279.93M

FY 2025 · Annual

+100.9% YoY

Liabilities

$55.04M

FY 2025 · Annual

+248.4% YoY

Equity

$224.89M

FY 2025 · Annual

+82.1% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents190.3M111.1M135.12M36.93M43.76M
Short-term Investments073.78M62.7M94.97M229.7M
Net Receivables5.84M2.54M4.85M3.12M1.74M
Inventory00000
Other Current Assets33.31K5.39M6.96M2.25M3M
Total Current Assets204.13M192.81M209.63M137.25M278.19M
Property, Plant & Equipment (Net)1.45M1.08M651K413K312K
Goodwill00000
Intangible Assets12.42M12.42M000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets872K615K363K1.64M1.43M
Total Non-current Assets14.74M14.12M1.01M2.05M1.74M
Total Assets218.87M206.93M210.64M139.31M279.93M
Account Payables2.03M4.8M2.07M211K2.72M
Short-term Debt00000
Tax Payables01.17M000
Deferred Revenue00000
Other Current Liabilities6.09M0000
Total Current Liabilities18.28M17.05M12.14M10.47M15M
Long-term Debt000034.29M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)0000160K
Other Non-current Liabilities330K3.91M4.22M3.93M4.45M
Total Non-current Liabilities1.45M4.58M4.4M5.33M40.04M
Total Liabilities19.73M21.64M16.54M15.8M55.04M
Common Stock4K5K7K7K11K
Retained Earnings(293.17M)(377.88M)(466.33M)(561.39M)(649.48M)
Accumulated OCI(5.04M)(5.23M)(5M)(4.97M)(4.93M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity199.14M185.29M194.1M123.51M224.89M
Total Debt1.54M1.12M671K1.68M35.69M
Net Debt(188.77M)(109.97M)(134.45M)(35.25M)(8.07M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$97.6M
Short-term Investments$233.9M
Receivables$1.7M
Other Current$1.5M
Total Current Assets$334.7M
PP&E (Net)$208.0K
Other Non-current$746.0K
Total Non-current Assets$954.0K
Total Assets$335.6M

Analysis

Selected assets total $335.6M for Latest. The largest visible component is Short-term Investments at $233.9M, about 69.7% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 13, 2026
4Statement of changes in beneficial ownershipNov 13, 2026
4Statement of changes in beneficial ownershipNov 13, 2026
4Statement of changes in beneficial ownershipNov 13, 2026
10-QQuarterly reportNov 12, 2026

How much cash does ALT have?

Altimmune, Inc. (ALT) reported $43.76M in cash and equivalents in fiscal 2025.

How much debt does ALT carry?

Altimmune, Inc. (ALT) reported $35.69M of total debt, with net debt of -$8.07M.